Enlivex Announces Positive Interim Data Readout from a Phase I/II Trial Evaluating Allocetra in End-Stage Knee Osteoarthritis

<div class="b2iNewsItemBodyDiv"><link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /><p style="padding-left:24px;"><strong>Key Highlights</strong></p> <ul type="disc"><li style="margin-top:5pt; margin-bottom:5pt;">Enrolled patients with severe knee osteoarthritis who were indicated for knee-replacement surgery received a single local injection of Allocetra^TM into the knee as a "last resort"</li><li style="margin-top:5pt;...